Saturday, November 1, 2025

Canada’s Politics and Government News Source Since 1989

Saturday, November 1, 2025 | Latest Paper

TRENDING:

Will the government stop the changes to PMPRB?

There has been significant opposition to new regulations, coming into effect on Jan. 1, 2022, from multiple stakeholders who express concerns that this will hollow out Canada’s medical R&D sector and delay the introduction of new drugs here by as much as a decade.

Many patient groups are urging the federal government not to bring in changes to the countries that Canada uses to compare drug prices, as recommended by the Patented Medicine Prices Review Board, which operates at arm’s-length from the Minister of Health Jean-Yves Duclos, pictured on Oct. 26. Many stakeholders worry that the regulations give too much power to an agency that operates at arms length from the government and is reluctant to hear (and sometimes openly dismissive of) input from key stakeholders like the patients who are most affected by drug prices, writes Doug Earle. The Hill Times photograph by Andrew Meade

Opinion
BY DOUG EARLE
December 1, 2021

Opinion | BY DOUG EARLE | December 1, 2021

FOLLOW THE HILL TIMES:

Want to make sure your whole office has the full Hill Times experience?

We have team plans available for companies, organizations, classes, Parliament Hill offices and more. Fill out this form and find out if your team is eligible for a discount.

More Opinion

Security delayed is security denied

OpinionBY LISA LAMBERT, MICHELE MOSCA

Who will protect our brains in the AI race?

OpinionBY VIVIANE POUPON

Carney’s budget challenge: govern for the many, or manage for the few?

OpinionBY BHAGWANT SANDHU

The easiest policy win in Ottawa might just be hiding in plain sight

OpinionBY ORVILLE BOVENSCHEN

For Canada to be ‘climate competitive’ we need to stay the course on key industrial policies

OpinionBY JANETTA MCKENZIE

Related Stories

All eyes on the Carney-Xi meeting

FeatureBY RIDDHI KACHHELA, PETER MAZEREEUW

Auditor General to probe Canada Revenue Agency’s phone system contract

NewsBY MARLO GLASS

Women’s groups hail ongoing funding for gender-equality programs, but warn the ‘devil is in the details’

NewsBY RIDDHI KACHHELA, SAMANTHA WRIGHT ALLEN

‘Cut through the table talk’: tech firms launch new group to help feds fix procurement woes

NewsBY IREM KOCA

Curing Type 1 diabetes could be Canada’s legacy

OpinionBY JESSICA DINIZ, CATE MURRAY

McPherson, Ashton, Lewis pitch anti-cat credentials in Mouseland

FeatureBY STUART BENSON

Hundreds of New Democrats painted SJAM orange on Oct. 28 at the Douglas Coldwell Layton Foundation’s annual gala.

McPherson, Ashton, Lewis pitch anti-cat credentials in Mouseland

FeatureBY STUART BENSON

Hundreds of New Democrats painted SJAM orange on Oct. 28 at the Douglas Coldwell Layton Foundation’s annual gala.